Molecular Investigation of Mitochondrial RNA19 Role in the Pathogenesis of MELAS Disease

Area of Science:

• Mitochondrial biology
• RNA processing
• Molecular genetics

Background:

• Mammalian mitochondrial RNA processing is complex, involving cleavage and modification of primary transcripts.
• RNA19, a stable polyadenylated precursor containing 16S mt-rRNA, mt-tRNALeuUUR, and mt-ND1 mRNA, is implicated in mitochondrial function and disease.
• Altered RNA19 levels are observed in cells with mitochondrial defects, highlighting its potential regulatory role.

Purpose of the Study:

• To investigate the role of RNA19 in MELAS (Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes) cybrids with the 3243A>G mtDNA mutation.
• To characterize the association of RNA19 with mitochondrial components in disease models.
• To explore the impact of LARS2 C-terminal domain expression on RNA19.

Main Methods:

• Quantitative and qualitative analysis of RNA19 in MELAS trans-mitochondrial cybrids.
• Isokinetic sucrose gradient centrifugation to assess RNA sedimentation.
• Reverse transcription quantitative polymerase chain reaction (RT-qPCR) to quantify RNA levels.

Main Results:

• RNA19 accumulated and co-sedimented with the mitochondrial large ribosomal subunit (mt-LSU) in MELAS cybrids.
• Exogenous expression of the LARS2 C-terminal domain reduced mt-LSU-associated RNA19 levels.
• RNA19 was redistributed to a pool of free, unbound RNAs following LARS2 C-terminal domain expression.

Conclusions:

• RNA19 plays a regulatory role in mitochondrial physiopathology.
• The association of RNA19 with the mt-LSU is altered in MELAS cybrids.
• RNA19 represents a potential molecular target for therapeutic strategies in mitochondrial diseases.